DK0527079T3 - N-(isoquinolin-5-yl)-sulfonyl-azacykloalkaner, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse - Google Patents

N-(isoquinolin-5-yl)-sulfonyl-azacykloalkaner, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK0527079T3
DK0527079T3 DK92402201.5T DK92402201T DK0527079T3 DK 0527079 T3 DK0527079 T3 DK 0527079T3 DK 92402201 T DK92402201 T DK 92402201T DK 0527079 T3 DK0527079 T3 DK 0527079T3
Authority
DK
Denmark
Prior art keywords
azacycloalkanes
isoquinolin
sulfonyl
preparation
pharmaceutical compositions
Prior art date
Application number
DK92402201.5T
Other languages
Danish (da)
English (en)
Inventor
Jean-Louis Peglion
Jean-Paul Vilaine
Nicole Villeneuve
Philip Janiak
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0527079T3 publication Critical patent/DK0527079T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK92402201.5T 1991-07-31 1992-07-31 N-(isoquinolin-5-yl)-sulfonyl-azacykloalkaner, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse DK0527079T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9109720A FR2679907B1 (fr) 1991-07-31 1991-07-31 Nouveaux n-[(isoquinolein-5 yl)sulfonyl] azacycloalcanes, leur procede de preparation et les compositions pharmaceutiques les contenant.

Publications (1)

Publication Number Publication Date
DK0527079T3 true DK0527079T3 (da) 1997-04-21

Family

ID=9415765

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92402201.5T DK0527079T3 (da) 1991-07-31 1992-07-31 N-(isoquinolin-5-yl)-sulfonyl-azacykloalkaner, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Country Status (14)

Country Link
US (1) US5298503A (de)
EP (1) EP0527079B1 (de)
JP (1) JPH0720954B2 (de)
AT (1) ATE144510T1 (de)
AU (1) AU645917B2 (de)
CA (1) CA2074963A1 (de)
DE (1) DE69214747T2 (de)
DK (1) DK0527079T3 (de)
ES (1) ES2095431T3 (de)
FR (1) FR2679907B1 (de)
GR (1) GR3021769T3 (de)
IE (1) IE922524A1 (de)
NZ (1) NZ243784A (de)
ZA (1) ZA925782B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011939A1 (fr) * 1995-09-28 1997-04-03 Kaken Pharmaceutical Co., Ltd. Procede d'elaboration de 4-methylenepiperidines
US5741798A (en) * 1996-06-03 1998-04-21 Boehringer Ingelheim Pharmaceuticals, Inc. 2-benzyl-4-sulfonyl-4H-isoquinolin-1,3-diones and their use as antiinflammatory agents
JP5220414B2 (ja) 2005-08-30 2013-06-26 旭化成ファーマ株式会社 スルホンアミド化合物
WO2008105058A1 (ja) * 2007-02-27 2008-09-04 Asahi Kasei Pharma Corporation スルホンアミド化合物
AU2008220104B2 (en) * 2007-02-28 2012-09-27 Asahi Kasei Pharma Corporation Sulfonamide derivative
JP5234825B2 (ja) * 2007-07-02 2013-07-10 旭化成ファーマ株式会社 スルホンアミド化合物及びその結晶
JP6108045B2 (ja) 2015-02-13 2017-04-05 ユニマテック株式会社 含フッ素共重合体およびこれを有効成分とする表面改質剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583287D1 (de) * 1984-12-27 1991-07-25 Asahi Chemical Ind Substituierte isochinolinsulfonyl-verbindungen.
JPH0667926B2 (ja) * 1985-11-12 1994-08-31 旭化成工業株式会社 環状のイソキノリンスルホンアミド誘導体

Also Published As

Publication number Publication date
FR2679907A1 (fr) 1993-02-05
DE69214747D1 (de) 1996-11-28
ES2095431T3 (es) 1997-02-16
CA2074963A1 (fr) 1993-02-01
AU2067592A (en) 1993-02-04
US5298503A (en) 1994-03-29
FR2679907B1 (fr) 1995-01-20
AU645917B2 (en) 1994-01-27
GR3021769T3 (en) 1997-02-28
NZ243784A (en) 1994-07-26
JPH05208973A (ja) 1993-08-20
DE69214747T2 (de) 1997-05-07
ZA925782B (en) 1993-03-02
EP0527079A1 (de) 1993-02-10
JPH0720954B2 (ja) 1995-03-08
IE922524A1 (en) 1993-02-10
EP0527079B1 (de) 1996-10-23
ATE144510T1 (de) 1996-11-15

Similar Documents

Publication Publication Date Title
NO920957L (no) Cykliske urinstoffderivater og legemidler inneholdende disse forbindelser
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0526342T3 (da) Isoquinolin-5-yl-sulfonamider, fremgangsmåde til fremstilling af sådanne forbindelser og farmaceutiske sammensætninger indeholdende disse
DK0478446T3 (da) Heterocykliske alkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK0624595T3 (da) Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
DK0506539T3 (da) heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
MY101791A (en) New benzimidazole derivatives
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
DK0618209T3 (da) Pyridothiadiaziner, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem
MY101784A (en) Novel pharmacological compounds
ES2107284T3 (es) Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
SE8404065D0 (sv) Novel biologically active compounds
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
DK0486386T3 (da) Hidtil ukendte N-benzoylprolinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
PT722319E (pt) Derivados de antraciclinona e a sua utilizacao no tratamento da amiloidose
DK0527079T3 (da) N-(isoquinolin-5-yl)-sulfonyl-azacykloalkaner, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK0632026T3 (da) Alfa-aminosyrederivater, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem
DK0564358T3 (da) 3-aminochroman-spiro-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne
ZA929855B (en) Pyrrolidine compounds process for preparing them and pharmaceutical compositions containing them
FI944751A0 (fi) Heteroaryylipiperidiinejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
NO942181D0 (no) Nye, substituerte oksazinoisokinolinderivater, farmasöytiske preparater inneholdende disse og fremgangsmåte for fremstilling av disse
DK0635491T3 (da) (Thia)cycloalkylab indoler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse forbindelser.
SE8704049D0 (sv) Novel pharmacological compounds
NO944748D0 (no) Nye biologiske aktive eburnameninderivater, farmasöytiske preparater inneholdende disse, og fremgangsmåte for fremstilling av disse
ES2076517T3 (es) Ergolinas disustituidas en posiciones 2,13, su preparacion y utilizacion en medicamentos.